We are live on ! Find out more
WP

Woodline Partners Portfolio holdings

AUM $26.4B
1-Year Est. Return 44.85%
This Fund
S&P 500
This Quarter Est. Return
+12.59%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$18.9B
AUM Growth
+$3.55B
Cap. Flow
+$2.11B
Cap. Flow %
11.15%
Top 10 Hldgs %
14.56%
Holding
1,090
New
199
Increased
468
Reduced
192
Closed
179

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$216M
2
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$129M
3
BRO icon
Brown & Brown
BRO
+$121M
4
AJG icon
Arthur J. Gallagher & Co
AJG
+$116M
5
AKRO
Akero Therapeutics
AKRO
+$90.3M

Top Sells

Rank Stock Value
1
LRCX icon
Lam Research
LRCX
+$144M
2
MET icon
MetLife
MET
+$97.2M
3
TRV icon
Travelers Companies
TRV
+$91.9M
4
EA icon
Electronic Arts
EA
+$91.9M
5
SWTX
SpringWorks Therapeutics
SWTX
+$76M

Sector Composition

Rank Sector Weight
1 Healthcare 25.08%
2 Technology 23.91%
3 Financials 10.59%
4 Consumer Discretionary 9.42%
5 Industrials 7.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ETOR
701
eToro Group
ETOR
$2.92B
$2.33M 0.01%
+35,000
New +$2.25M
TSHA icon
702
Taysha Gene Therapies
TSHA
$1.71B
$2.31M 0.01%
1,000,254
+142,000
+17% +$309K
TROW icon
703
T. Rowe Price
TROW
$24.1B
$2.3M 0.01%
23,832
+5,023
+27% +$461K
RF icon
704
Regions Financial
RF
$27.2B
$2.29M 0.01%
97,236
+20,439
+27% +$433K
NXPI icon
705
NXP Semiconductors
NXPI
$59.7B
$2.28M 0.01%
+10,453
New +$2.04M
ADCT icon
706
ADC Therapeutics
ADCT
$137M
$2.26M 0.01%
842,900
+27,369
+3% +$57.6K
CMS icon
707
CMS Energy
CMS
$22.5B
$2.24M 0.01%
32,356
+7,113
+28% +$507K
FE icon
708
FirstEnergy
FE
$27.9B
$2.24M 0.01%
55,568
+12,234
+28% +$505K
WSM icon
709
Williams-Sonoma
WSM
$29.5B
$2.17M 0.01%
13,299
+2,899
+28% +$455K
INTA icon
710
Intapp
INTA
$2.54B
$2.16M 0.01%
41,819
-101,215
-71% -$5.53M
TPL icon
711
Texas Pacific Land
TPL
$27.9B
$2.15M 0.01%
6,117
+1,341
+28% +$548K
EIX icon
712
Edison International
EIX
$27.6B
$2.15M 0.01%
41,620
+8,911
+27% +$488K
INZY
713
DELISTED
Inozyme Pharma
INZY
$2.14M 0.01%
535,185
-468,554
-47% -$1.16M
SANA icon
714
Sana Biotechnology
SANA
$924M
$2.13M 0.01%
781,222
+566
+0.1% +$1.17K
DLTR icon
715
Dollar Tree
DLTR
$25.1B
$2.12M 0.01%
21,368
+4,290
+25% +$370K
GPN icon
716
Global Payments
GPN
$23.8B
$2.11M 0.01%
26,380
-173,113
-87% -$13.7M
RAPP
717
Rapport Therapeutics
RAPP
$1.99B
$2.1M 0.01%
185,028
+3,000
+2% +$31.8K
CFG icon
718
Citizens Financial Group
CFG
$31.2B
$2.1M 0.01%
46,908
+9,976
+27% +$393K
NSC icon
719
Norfolk Southern
NSC
$76.2B
$2.08M 0.01%
8,133
+7,286
+860% +$1.72M
MKC icon
720
McCormick & Company Non-Voting
MKC
$13.9B
$2.07M 0.01%
27,332
+5,998
+28% +$449K
HNGE
721
Hinge Health
HNGE
$6.25B
$2.07M 0.01%
+40,000
New +$1.62M
NI icon
722
NiSource
NI
$21.3B
$2.05M 0.01%
50,915
+11,212
+28% +$440K
MT icon
723
ArcelorMittal
MT
$56.2B
$2.04M 0.01%
+64,672
New +$1.91M
PRGO icon
724
Perrigo
PRGO
$1.46B
$2.03M 0.01%
75,819
– –
TPR icon
725
Tapestry
TPR
$31.7B
$1.97M 0.01%
22,438
+4,948
+28% +$375K
27 28
29
30 31

Similar funds

PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
TCIIS
TIAA-CREF Individual & Institutional Services New York $26B AUM
WorldQuant Millennium Advisors
WorldQuant Millennium Advisors New York $25.9B AUM 22.07% 1-Year Est. Return
Nisa Investment Advisors
Nisa Investment Advisors St. Louis, Missouri $27B AUM 24.49% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
UIM
USS Investment Management London, United Kingdom $25.6B AUM 30.22% 1-Year Est. Return
VAI
Vanguard Advisers Inc Malvern, Pennsylvania $25.5B AUM

Woodline Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Woodline Partners held 1,090 positions worth $18.9B, up 23% from $15.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Woodline Partners deployed $2.11B of net new capital in Q2 2025, opening 199 new positions and adding to 468 existing holdings. Its largest new stake was Brown & Brown: 1,079,076 shares worth $120M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, down from 30% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was SpringWorks Therapeutics, an estimated $76M trimmed.

  • Woodline Partners's largest Q2 2025 buy was Brown & Brown: 1,079,076 shares worth $120M.
  • Woodline Partners added most to Microsoft in Q2 2025, an estimated $216M increase.
  • Woodline Partners's biggest Q2 2025 reduction was SpringWorks Therapeutics, cutting an estimated $76M.
  • Woodline Partners fully exited Lam Research in Q2 2025, selling an estimated $144M.
  • Woodline Partners's ten largest holdings make up 15% of its $18.9B portfolio in Q2 2025.
  • Woodline Partners opened 199 new positions and closed 179 in Q2 2025.
  • Woodline Partners's portfolio value rose 23% quarter-over-quarter to $18.9B.

Based on Woodline Partners's 13F filing for Q2 2025, filed 14 Aug 2025.